PL435352A1 - Formulation of freeze-dried eggs of Helix aspersa aspersa snails and an aqueous extract of this preparation, as well as method of their preparation and application - Google Patents

Formulation of freeze-dried eggs of Helix aspersa aspersa snails and an aqueous extract of this preparation, as well as method of their preparation and application

Info

Publication number
PL435352A1
PL435352A1 PL435352A PL43535220A PL435352A1 PL 435352 A1 PL435352 A1 PL 435352A1 PL 435352 A PL435352 A PL 435352A PL 43535220 A PL43535220 A PL 43535220A PL 435352 A1 PL435352 A1 PL 435352A1
Authority
PL
Poland
Prior art keywords
preparation
aspersa
aqueous extract
freeze
snails
Prior art date
Application number
PL435352A
Other languages
Polish (pl)
Other versions
PL245449B1 (en
Inventor
Magdalena Matusiewicz
Iwona Kosieradzka
Tomasz Niemiec
Klara Zglińska
Karolina Marczak
Barbara Kwiecińska
Julia Kupis
Original Assignee
Szkoła Główna Gospodarstwa Wiejskiego w Warszawie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Szkoła Główna Gospodarstwa Wiejskiego w Warszawie filed Critical Szkoła Główna Gospodarstwa Wiejskiego w Warszawie
Priority to PL435352A priority Critical patent/PL245449B1/en
Publication of PL435352A1 publication Critical patent/PL435352A1/en
Publication of PL245449B1 publication Critical patent/PL245449B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Przedmiotem wynalazku jest preparat z liofilizowanych jaj ślimaków H. aspersa aspersa i jego wodny ekstrakt jako ważne źródła naturalnych związków wykazujących działanie przeciwnowotworowe, zwłaszcza w terapiach kombinowanych. Przedmiotem wynalazku jest również sposób otrzymywania preparatu i jego wodnego ekstraktu oraz ich terapeutyczne zastosowanie w leczeniu nowotworu jelita grubego.The subject of the invention is the preparation of freeze-dried eggs of H. aspersa aspersa snails and its aqueous extract as important sources of natural compounds with anticancer activity, especially in combination therapies. The subject of the invention is also a method of obtaining the preparation and its aqueous extract and their therapeutic use in the treatment of colorectal cancer.

PL435352A 2020-09-18 2020-09-18 Method of obtaining a preparation and an aqueous extract from lyophilized Helix aspersa aspersa snail eggs and the use of the obtained preparation and its aqueous extract in the treatment of colon cancer PL245449B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL435352A PL245449B1 (en) 2020-09-18 2020-09-18 Method of obtaining a preparation and an aqueous extract from lyophilized Helix aspersa aspersa snail eggs and the use of the obtained preparation and its aqueous extract in the treatment of colon cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL435352A PL245449B1 (en) 2020-09-18 2020-09-18 Method of obtaining a preparation and an aqueous extract from lyophilized Helix aspersa aspersa snail eggs and the use of the obtained preparation and its aqueous extract in the treatment of colon cancer

Publications (2)

Publication Number Publication Date
PL435352A1 true PL435352A1 (en) 2022-03-21
PL245449B1 PL245449B1 (en) 2024-08-05

Family

ID=80739307

Family Applications (1)

Application Number Title Priority Date Filing Date
PL435352A PL245449B1 (en) 2020-09-18 2020-09-18 Method of obtaining a preparation and an aqueous extract from lyophilized Helix aspersa aspersa snail eggs and the use of the obtained preparation and its aqueous extract in the treatment of colon cancer

Country Status (1)

Country Link
PL (1) PL245449B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL443639A1 (en) * 2023-01-31 2024-08-05 Uniwersytet Śląski W Katowicach Condensate from Cornu aspersum snail eggs, method of its production and use, and a cosmetic composition based on condensate from Cornu aspersum snail eggs

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL443639A1 (en) * 2023-01-31 2024-08-05 Uniwersytet Śląski W Katowicach Condensate from Cornu aspersum snail eggs, method of its production and use, and a cosmetic composition based on condensate from Cornu aspersum snail eggs

Also Published As

Publication number Publication date
PL245449B1 (en) 2024-08-05

Similar Documents

Publication Publication Date Title
CO2023004252A2 (en) Anti-ceacam5 antibodies and conjugates and uses thereof
PH12020551043A1 (en) Compounds, compositions, and methods for treatment of diseases involving acidic or hypoxic diseased tissues
BR112019010020A2 (en) compounds with anti-tumor activity against cancer cells containing egfr or her2 exon mutations
CL2019000277A1 (en) Joint treatment against cancer.
MX2019001920A (en) Rna for cancer therapy.
WO2019197605A3 (en) Drug combinations for use in the treatment of ras-mutant cancer
MX2019008350A (en) Subcutaneous her2 antibody formulations.
MX2018003331A (en) Administration of deuterated cftr potentiators.
MX2020012799A (en) COMPOSITION AND METHOD TO TREAT CANCER ASSOCIATED WITH EGFR MUTATION.
ZA202202363B (en) Antibodies against ilt2 and use thereof
ZA201907225B (en) Treatment of her2 positive cancers
NO20071426L (en) Cancer combination therapy including AZD2171 and Imatinib
BR112015026247A2 (en) methods for cancer treatment using tor kinase inhibitor combination therapy
AR075982A1 (en) COMBINATION THERAPY OF A AFUCOSILATED ANTIBODY AND ONE OR MORE OF THE SELECTED CYTOKINS OF GM-CSF HUMAN, M-CSF HUMAN AND / OR IL-3 HUMAN AND COMPOSITION
MX2021015533A (en) Anti-mesothelin antibodies and immunoconjugates thereof.
MX2021015974A (en) CONJUGATES OF ANTIBODIES AND ANTI-TISULAR FACTOR DRUGS AND RELATED METHODS.
CY1122892T1 (en) 3-(CARBOXYMETHYL)-8-AMINO-2-OXO-1,3-DIAZA-SPIRO-[4.5]-DECANE DERIVATIVES
EA202091112A1 (en) SOCRYSTALS, PHARMACEUTICAL COMPOSITIONS BASED ON THEIR BASED AND METHODS OF TREATMENT FOR THEIR APPLICATION
EA201792294A1 (en) COMBINED TREATMENT (OPTIONS) WITH THE USE OF SERIBANTUMAB
CL2020000508A1 (en) Anti-egfr drug-antibody (adc) conjugates and their uses.
EA202191165A1 (en) ELACESTRANT IN COMBINATION WITH ABEMACYCLIBUS IN WOMEN WITH BREAST CANCER
MX2023006087A (en) Lyophilized formulations of tegavivint.
PL435352A1 (en) Formulation of freeze-dried eggs of Helix aspersa aspersa snails and an aqueous extract of this preparation, as well as method of their preparation and application
PL435353A1 (en) Formulation of freeze-dried eggs of Helix aspersa maxima snails and an aqueous extract of this formulation, as well as method of their preaparation and application
CL2019000846A1 (en) Therapeutic protein.